DXCM
Price
$71.54
Change
+$1.06 (+1.50%)
Updated
Jul 24 closing price
Capitalization
27.61B
4 days until earnings call
Intraday BUY SELL Signals
NVST
Price
$26.33
Change
+$0.16 (+0.61%)
Updated
Jul 24 closing price
Capitalization
4.28B
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DXCM vs NVST

DXCM vs NVST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DXCM vs. NVST commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and NVST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2026
Stock price -- (DXCM: $71.54 vs. NVST: $26.33)
Brand notoriety: DXCM and NVST are both not notable
DXCM represents the Medical/Nursing Services, while NVST is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DXCM: 38% vs. NVST: 67%
Market capitalization -- DXCM: $27.61B vs. NVST: $4.28B
DXCM [@Medical/Nursing Services] is valued at $27.61B. NVST’s [@Pharmaceuticals: Other] market capitalization is $4.28B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $179.51B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $119.23B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 1 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • DXCM’s FA Score: 1 green, 4 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, DXCM is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 4 TA indicator(s) are bullish while NVST’s TA Score has 6 bullish TA indicator(s).

  • DXCM’s TA Score: 4 bullish, 5 bearish.
  • NVST’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NVST is a better buy in the short-term than DXCM.

Price Growth

DXCM (@Medical/Nursing Services) experienced а -6.67% price change this week, while NVST (@Pharmaceuticals: Other) price change was -1.53% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.78%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -21.89%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.53%. For the same industry, the average monthly price growth was -1.01%, and the average quarterly price growth was -10.46%.

Reported Earning Dates

DXCM is expected to report earnings on Jul 30, 2026.

NVST is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-5.78% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-3.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($27.6B) has a higher market cap than NVST($4.29B). NVST has higher P/E ratio than DXCM: NVST (64.22) vs DXCM (30.70). NVST YTD gains are higher at: 21.281 vs. DXCM (7.790). DXCM has higher annual earnings (EBITDA): 1.48B vs. NVST (388M). DXCM has more cash in the bank: 2.42B vs. NVST (1.08B). DXCM has less debt than NVST: DXCM (1.39B) vs NVST (1.59B). DXCM has higher revenues than NVST: DXCM (4.82B) vs NVST (2.81B).
DXCMNVSTDXCM / NVST
Capitalization27.6B4.29B644%
EBITDA1.48B388M381%
Gain YTD7.79021.28137%
P/E Ratio30.7064.2248%
Revenue4.82B2.81B172%
Total Cash2.42B1.08B223%
Total Debt1.39B1.59B87%
FUNDAMENTALS RATINGS
DXCM vs NVST: Fundamental Ratings
DXCM
NVST
OUTLOOK RATING
1..100
5088
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
2890
PRICE GROWTH RATING
1..100
5048
P/E GROWTH RATING
1..100
9451
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (61) in the null industry is in the same range as DXCM (75) in the Medical Specialties industry. This means that NVST’s stock grew similarly to DXCM’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as DXCM (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's SMR Rating (28) in the Medical Specialties industry is somewhat better than the same rating for NVST (90) in the null industry. This means that DXCM’s stock grew somewhat faster than NVST’s over the last 12 months.

NVST's Price Growth Rating (48) in the null industry is in the same range as DXCM (50) in the Medical Specialties industry. This means that NVST’s stock grew similarly to DXCM’s over the last 12 months.

NVST's P/E Growth Rating (51) in the null industry is somewhat better than the same rating for DXCM (94) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMNVST
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 13 days ago
69%
Bullish Trend 10 days ago
64%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
67%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signal:
Gain/Loss:
NVST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYX1.150.01
+0.88%
SKYX Platforms Corp
CCI74.900.33
+0.44%
Crown Castle
BDC102.76-0.27
-0.26%
Belden
AMPH18.72-0.15
-0.79%
Amphastar Pharmaceuticals
BMGL5.43-0.37
-6.38%
Basel Medical Group Ltd

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with ISRG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+1.50%
ISRG - DXCM
46%
Loosely correlated
+1.65%
ALGN - DXCM
44%
Loosely correlated
-0.73%
NVST - DXCM
40%
Loosely correlated
+0.61%
SYK - DXCM
40%
Loosely correlated
+3.54%
GKOS - DXCM
39%
Loosely correlated
+0.95%
More